A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
NCT00082082
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
DRUG:
Thymalfasin (thymosin alpha-1)
PROCEDURE:
Trans arterial chemoembolization (TACE)
Sponsor
SciClone Pharmaceuticals